PHARMACYTE BIOTECH, INC. Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31)
PHARMACYTE BIOTECH, INC. (PMCB) had Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) of $1.50 million as of 2013-07-31, per its 10-Q filed 2013-09-16.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets · last filed 2013-09-16
- 2013-07-31: Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) $1.50M.
- 2013-04-30: Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) $1.52M.
- 2013-01-31: Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) $1.36M.
- 2012-10-31: Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) $1.20M.
| Period end | Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) |
|---|---|
| 2013-07-31 | $1.50M 10-Q · filed 2013-09-16 |
| 2013-04-30 | $1.52M 10-Q · filed 2013-09-16 |
| 2013-01-31 | $1.36M 10-Q · filed 2013-03-26 |
| 2012-10-31 | $1.20M 10-Q · filed 2012-12-26 |
| 2012-07-31 | $1.07M 10-Q · filed 2012-09-19 |
| 2012-04-30 | $874.23K 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |